JETRO AnnouncementsSuccess Stories:Johnson & Johnson Innovation

Aug 18, 2021

Johnson & Jonson Innovation, together with Takeda Pharmaceutical Company Limited, Shonan Health Innovation Park (Shonan iPark), co-hosted a research incubation project called “World Without Disease Call-for-Proposal," and as a company-led project in the healthcare industry in Japan, this was the first incubation project through public invitation for early seeds in which multiple companies collaborated. Through effective collaboration combining Johnson & Jonson Innovation's expertise and global network with the ecosystem base that Takeda Pharmaceutical and Shonan iPark have in Japan, it aimed to discover promising seeds in Japan and form an ecosystem to market those seeds globally.

We interviewed Dr. Dan Wang, Head of Johnson & Johnson Innovation Asia Pacific, Dr. Jun Kusunoki, Director of Early Innovation Partnering, Japan, Johnson & Johnson Innovation Asia Pacific, and Dr. Toshio Fujimoto, General Manager of Shonan iPark about the background of the collaboration, the results of the incubation project, and the Japanese healthcare industry. For the video of this interview, watch it here (Full VersionExternal site: a new window will open/Short VersionExternal site: a new window will open).

Establishment
1998/
Destination
Tokyo

  • Biotechnology & Lifescience
  • USA

Contact Us

Investing in Japan

We will do our very best to support your business expansion into and within Japan. Please feel free to contact us via the form below for any inquiries.

Inquiry Form

JETRO Worldwide

Our network covers over 50 countries worldwide. You can contact us at one of our local offices near you for consultation.

Worldwide Offices